Trelegy Ellipta is not currently available in generic form. As of late 2023, no generic versions have been approved by the U.S. Food and Drug Administration (FDA).
When Might Generic Trelegy Ellipta Become Available?
The availability of generic versions of Trelegy Ellipta depends on patent expirations and any associated market exclusivities. Information on specific patent and exclusivity dates for Trelegy Ellipta can be found through resources like DrugPatentWatch.com [1]. Patent challenges or litigation can also affect the timeline for generic entry.
What is Trelegy Ellipta Used For?
Trelegy Ellipta is a once-daily inhaler approved for the maintenance treatment of patients with asthma or chronic obstructive pulmonary disease (COPD) [2]. It combines three active ingredients: fluticasone furoate (an inhaled corticosteroid), umeclidinium (a long-acting muscarinic antagonist), and vilanterol (a long-acting beta2-adrenergic agonist) [3].
How Does Trelegy Ellipta Work?
The combination of these three medications in Trelegy Ellipta addresses COPD and asthma through different mechanisms. Fluticasone furoate reduces airway inflammation. Umeclidinium helps to relax the muscles around the airways, making breathing easier. Vilanterol also relaxes airway muscles, providing bronchodilation [3].
What Are the Alternatives to Trelegy Ellipta?
For patients with asthma and COPD, there are various treatment options available, including other inhalers that may contain one, two, or three different types of medications [4]. These alternatives may include different combinations of inhaled corticosteroids, long-acting beta-agonists, and long-acting muscarinic antagonists, or they may involve different delivery devices [4]. The choice of treatment often depends on the individual patient's condition, severity of disease, and response to therapy [4].
Who Manufactures Trelegy Ellipta?
Trelegy Ellipta is manufactured by GlaxoSmithKline (GSK) [2].
What Are the Potential Side Effects of Trelegy Ellipta?
Common side effects associated with Trelegy Ellipta include pneumonia, headache, and the common cold [3]. Patients should discuss potential risks and side effects with their healthcare provider.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugbank.com/drugs/Trelegy-Ellipta
[3] https://www.rxlist.com/trelegy-ellipta-side-effects-drug-center.htm
[4] https://www.ncbi.nlm.nih.gov/books/NBK556601/